AGP Executive Report
Last update: 26 minutes agoAviation & Travel: Qantas has confirmed Project Sunrise nonstop flights between Sydney and London will launch in October 2027, with the first Airbus A350-1000ULR unveiled and tickets expected to go on sale in February 2027. Energy & Jobs: Unions say they’ve struck a deal with Inpex to end strikes at the Ichthys LNG facilities, with cargo loading recommencing after missed loadings and an estimated $200m in lost earnings. Housing & Planning: South Australia’s housing reforms are driving a surge in approvals, with dwelling approvals hitting an all-time high and planning decisions moving far faster than Victoria and NSW. Public Health: The National Bowel Cancer Screening Program is showing improving uptake, with most participants returning for the next round. Health & Safety: A nasal spray aimed at stopping respiratory viruses before they take hold is advancing to Phase 2 trials, while researchers also highlight the mental-health risks of relationship breakups for men. Business & Finance: Paymentology and Kobble have partnered to speed up embedded finance rollouts across Australia, and Qantas’ ultra-long-haul push signals continued investment in major infrastructure.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/7b830788-22b5-4951-ae13-795b8c21bc2d/north-america-glp-1-receptor-agonist-market-size-2025-to-2035-usd-billion-.png)
